EUVIMEDEUVIMED entdecken
Open Access

Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer

Zhouda Cai, Jianming Lu, Shanshan Mo, Jipu Liu, Chuanfan Zhong, Yongding Wu, Fen Zou, Jianheng Ye, Zhaodong Han, Yuxiang Liang, Le Zhang, Fengping Liu und 1 weitere

Acta Biochimica et Biophysica Sinica · 2026

DOI: 10.3724/abbs.2025257 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2026. Verfasst von Zhouda Cai und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China. Hauptthemen laut MEDLINE: Glycolysis, Drug Resistance, Neoplasm, Prostatic Neoplasms, Membrane Proteins. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisDrug Resistance, NeoplasmProstatic NeoplasmsMembrane ProteinsMaleHumansPrognosisBenzamidesNitrilesCell Line, TumorPhenylthiohydantoinCell ProliferationMetabolic Reprogramming

Stichwörter der Autor:innen

AR signaling inhibitorCLN6enzalutamideglycolysislethal prostate cancer

Substanzen

BenzamidesNitrilesMembrane ProteinsPhenylthiohydantoinenzalutamide

Autor:innen und Institutionen

  • State Key Laboratory of Mechanism and Quality of Chinese Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China.
  • Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
  • Institute for Integrative Genome Biology, University of California, Riverside 92507, California, United States.
  • School and Hospital of Stomatology, Guangdong Engineering Research Center of Oral Restoration and Reconstruction & Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou Medical…
  • Faculty of Medicine, Macau University of Science and Technology, Taipa 999078, Macau, China.

Zitieren

APA

Cai, Z., Lu, J., Mo, S., Liu, J., Zhong, C., Wu, Y., Zou, F., Ye, J., Han, Z., Liang, Y., Zhang, L., Liu, F., & Zhong, W. (2026). Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025257

Vancouver

Cai Z, Lu J, Mo S, Liu J, Zhong C, Wu Y, et al. Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer. Acta Biochimica et Biophysica Sinica. 2026. doi:10.3724/abbs.2025257

BibTeX
@article{Cai2026,
  author = {Cai, Zhouda and Lu, Jianming and Mo, Shanshan and Liu, Jipu and Zhong, Chuanfan and Wu, Yongding and Zou, Fen and Ye, Jianheng and Han, Zhaodong and Liang, Yuxiang and Zhang, Le and Liu, Fengping and Zhong, Weide},
  title = {Glycolysis reprogramming predicts poor prognosis and drives therapy resistance via CLN6 in lethal prostate cancer},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2026},
  doi = {10.3724/abbs.2025257}
}
Kostenlos starten →